EcoDrugPlus

Ensembl ID : ENSHHUG00000034125
Gene Symbol: -
Cross references: -
135 Possible Orthologues:

Ensembl ID : ENSHHUG00000000596
Gene Symbol: -
Cross references: -
250 Possible Orthologues:

Ensembl ID : ENSHHUG00000037489
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSHHUG00000037492
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSHHUG00000000260
Gene Symbol: VEGFAA
1 Cross references
172 Possible Orthologues:

Ensembl ID : ENSHHUG00000037537
Gene Symbol: -
Cross references: -
182 Possible Orthologues:

Ensembl ID : ENSHHUG00000012574
Gene Symbol: -
Cross references: -
3 Possible Orthologues:

Ensembl ID : ENSHHUG00000033928
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSHHUG00000000134
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSHHUG00000039339
Gene Symbol: -
Cross references: -
133 Possible Orthologues:

Ensembl ID : ENSHHUG00000032949
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSHHUG00000050490
Gene Symbol: -
1 Cross references
223 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).